降钙素原检测对于盆腔炎的诊断价值分析

Abstract
Figure/Table
References (18)
Related Citation (15)

Download: PDF (0 KB) HTML (33 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the diagnostic value of procalcitonin (PCT) in the treatment of pelvic inflammatory disease.Methods A retrospective analysis was conducted on 120 patients with suspected pelvic inflammatory disease admitted to our hospital from June 2017 to May 2019 were enrolled in the study.The levels of serum PCT and C-reactive protein (CRP) before and after treatment were measured by automatic biochemical analyzer.Specificity,positive predictive value,negative predictive value,and accuracy of PCT and CRP in the diagnosis of pelvic inflammatory disease.Results Of the 120 patients with suspected pelvic inflammatory disease had definite pathogen infection after laboratory examination (all patients had typical clinical symptoms and signs of pelvic inflammatory disease).Finally,49 patients were diagnosed with pelvic inflammatory disease by laparoscopy and 71 patients with non-pelvic inflammatory disease.Serum PCT examination results confirmed 54 patients with pelvic inflammatory disease,including 16 false positives;serum CRP examination results confirmed 51 patients with pelvic inflammatory disease,including 25 false positives.The sensitivity,positive predictive value,negative predictive value and accuracy of PCT diagnosis of pelvic inflammatory disease were higher than serum CRP,the difference was statistically significant (P<0.05).Conclusion PCT has a high diagnostic value for pelvic inflammatory disease and can be used to guide clinical rational selection of treatment options.

Key words： Procalcitonin Pelvic inflammatory disease Diagnosis and treatment Clinical value analysis

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	FANG Dan-mei
	LIN Xiao-jin

Cite this article:

FANG Dan-mei,LIN Xiao-jin. Diagnostic value of procalcitonin in the treatment of pelvic inflammatory disease[J]. 中国当代医药, 2020, 27(14): 134-136转140.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2020/V27/I14/134

[1]	Lee L.Pelvic inflammatory disease[J].J Am Physician Assistants，2017，30（2）：47-48.
[2]	黄晓梅.盆腔炎的诊断和治疗研究进展[J].中国处方药，2017，15（5）：25-26.
[3]	Hu L，Shi Q，Shi M，et al.Diagnostic value of PCT and CRP for detecting serious bacterial infections in patients with fever of unknown origin，a systematic review and Meta-analysis[J].Appl Immunohistochem Mol Morp，2017，25（8）：e61-e69.
[4]	束龙文，唐杰，张宗新.Presepsin在急性盆腔炎诊断及疗效评估中的临床价值[J].中国卫生检验杂志，2016，26（20）：2942-2944.
[5]	吕越.血清降钙素原检验在妇科感染性疾病治疗中的价值研究[J].实用妇科内分泌杂志（电子版），2015，19（2）：96-96.
[6]	中华医学会妇产科学分会感染性疾病协作组.盆腔炎症性疾病诊治规范（修订版）[J].中国社区医师，2014，49（24）：42-43.
[7]	吴文湘，廖秦平.盆腔炎性疾病诊治策略专题讨论——盆腔炎性疾病的流行病学[J].实用妇产科杂志，2013，29（10）：721-723.
[8]	吉宁，刘世炜，曾新颖，等.2016年中国妇科疾病的疾病负担研究[J].中华妇产科杂志，2018，53（5）：313-318.
[9]	刘克玲.中国部分城市已婚妇女妇科常见病流行病学调查[J].中国妇幼保健，2001，16（5）：298-302.
[11]	樊海燕.降钙素原在感染性疾病中的应用价值[J].现代中西医结合杂志，2015，24（1）：89-91.
[12]	宇世飞，李芳秋.降钙素原的临床应用进展[J].医学研究生学报，2016，29（2）：206-209.
[13]	刘宠，彭子元，吴永华.血清降钙素原检测在感染性疾病和非感染性疾病诊治中的临床应用进展[J].山东医药，2019，59（3）：106-109.
[14]	赵志鹏，王利君，李润清，等.降钙素原在不同感染部位和类型中的应用价值[J].中国实验诊断学，2017，21（12）：2112-2115.
[15]	Thomas-Rüddel DO，Poidinger B，Kott M，et al.Influence of pathogen and focus of infection on procalcitonin values in sepsis patients with bacteremia or candidemia[J].Critical Care，2018，22（1）：128.
[16]	杨欣悦，钱传云，樊楚明.高敏C-反应蛋白与降钙素原对感染性疾病预后评估研究[J].中华医院感染学杂志，2014，24（1）：22-24.
[17]	郑明阳.降钙素原测定对重症盆腔炎性疾病的临床价值[J].中国妇幼保健，2014，29（35）：5778-5779.
[18]	张梦娜，裴红红.降钙素原临床研究进展[J].创伤与急危重病医学，2017，5（3）：181-183.
[10]	张展，刘朝晖.盆腔炎性疾病的诊治进展[J].中国实用妇科与产科杂志，2019，35（4）：109-113.